TCF4 and breast cancer: Let-7 has been reported to activate the WNT signaling pathway via targeting estrogen receptors in breast cancer, and transcription factor 4 (TCF-4; a downstream target of WNT) in hepatocellular carcinoma (HCC), resulting in increased cancer stemness and aggressiveness [67].